Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 19, 2020
Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice VariationsRick A Vreman, Aukje K Mantel-Teeuwisse, Anke M Hövels, et al.
Pharmacology Research & Perspectives|March 22, 2021
Bridging the gap: Can International Consortium of Health Outcomes Measurement standard sets align outcomes accepted for regulatory and health technology assessment decision-making of oncology medicinesRachel R J Kalf, Rick A Vreman, Diana M J Delnoij, et al.
Drug Safety|February 22, 2023
Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods StudyComfort K Ogar, Jonathan Quick, Hannah N Gilbert, et al.
BMJ Open|August 5, 2017
Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation modelRick A Vreman, Alex J Goodell, Luis A Rodriguez, et al.
International Journal of Technology Assessment in Health Care|January 31, 2022
Addressing uncertainty in relative effectiveness assessments by HTA organizationsRick A Vreman, George Strigkos, Hubert G M Leufkens, et al.
BMJ Open|February 14, 2024
Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysisLi Jiu, Michiel Hartog, Junfeng Wang, et al.
Pharmacoeconomics|December 14, 2020
The Application and Implications of Novel Deterministic Sensitivity Analysis MethodsRick A Vreman, Joost W Geenen, Saskia Knies, et al.
Cost Effectiveness and Resource Allocation : C/E|December 9, 2020
Increasing the information provided by probabilistic sensitivity analysis: The relative density plotJoost W Geenen, Rick A Vreman, Cornelis Boersma, et al.
Applied Health Economics and Health Policy|July 19, 2019
Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic LeukaemiaRick A Vreman, Joost W Geenen, Anke M Hövels, et al.
Psychopharmacology|February 25, 2014
Effects of alcohol hangover on simulated highway driving performanceJoris C Verster, Adriana C Bervoets, Suzanne de Klerk, et al.
Pageof 5